Commercialization, • 9/19/25 Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Previous What Matters to Payers: Conversations You Should Start During Phase 2 Next Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization You Might Also Like Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Operationalizing Precision Medicine in Rare Disease Trials Opening Keynote: The Future of Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2
Commercialization, • 9/19/25 Real-World Evidence That Matters: A Hands-On Workshop in Building Credible Value Stories Previous What Matters to Payers: Conversations You Should Start During Phase 2 Next Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization You Might Also Like Conducting Rare Disease Clinical Trials to Support Market Access and Commercialization Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Operationalizing Precision Medicine in Rare Disease Trials Opening Keynote: The Future of Rare Disease Trials What Matters to Payers: Conversations You Should Start During Phase 2
